Drug Trial Radar · NCT06455059
Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
81
Actual
Start
Jun 17, 2024
Primary completion
Apr 23, 2026
Study completion Apr 23, 2026
Sponsor
- Lead sponsor
- BioMarin PharmaceuticalBioMarin (BMRN)
- Sponsor type
- Industry
- First posted
- Jun 12, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 3 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The intent and design of this Phase 3 study is to assess vosoritide as a therapeutic option for the treatment of children with hypochondroplasia (HCH).
Conditions
- Hypochondroplasia
Interventions
VosoritideDrug
Subcutaneous injection of recommended dose of vosoritide based on weight-band dosing once daily.
PlaceboDrug
Subcutaneous injection of recommended dose of placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in annualized growth velocity (AGV) at Week 52 versus placeboTime frame: At week 52
Locations
23 sites in 9 countries. Site status is shown where the registry gives one.
Nemours Alfred I. DuPont Hospital for Children
Wilmington, Delaware
Children's National Medical Center
Washington D.C., District of Columbia
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois
Medical College of Wisconsin
Milwaukee, Wisconsin
Murdoch Children's Research Institute
Parkville, Victoria, Australia
University of Alberta Stollery Children's Hospital
Edmonton, Alberta, Canada
SickKids - The Hospital for Sick Children
Toronto, Ontario, Canada
Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
Hospices Civils de Lyon - Hopital Femme Mere Enfant
Lyon, France
Hopital de la Timone
Marseille, France
Hopital Necker-Enfants Malade
Paris, France
CHU de Toulouse
Toulouse, France
Uniklinik Koln
Cologne, Germany
Univeristatskinderklinik Magdeburg
Magdeburg, Germany
Instituto Giannina Gaslini
Genoa, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy
Ospedale Pediatrico Bambino Gesu
Rome, Italy
Osaka University Hosptial
Osaka, Japan
Tokushima University Hospital
Tokushima, Japan
Institute of Science Tokyo Hospital
Tokyo, Japan
Tottori University Hospital
Tottori, Japan
Vithas Hospital San Jose
Vitoria-Gasteiz, Spain
Great Ormond Street Hospital for Children NHS Foundation Trust
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.